The assay is a competitive EIA for the quantitative measurement of Pregnanediol-3a-Glucuronide (PDG) in human urine. Urine samples to be measured are diluted in Assay Buffer. Pregnanediol-3a-Glucuronide in the diluted sample then equilibrates with an anti-Pregnanediol-3a-Glucuronide rabbit antibody and alkaline phosphatase labelled Pregnanediol-3a-Glucuronide. Separation of free Pregnanediol-3a-Glucuronide from antibody-bound Pregnanediol-3a-Glucuronide is achieved by means of a magnetic anti-rabbit separation reagent. A further incubation with substrate produces colour in inverse proportion to the amount of Pregnanediol-3a-Glucuronide present. The assay has four main stages:
Urine samples and Pregnanediol-3a-Glucuronide standards are prepared by dilution in Assay Buffer.
Alkaline phosphatase labelled Pregnanediol-3a-Glucuronide, anti-Pregnanediol-3a-Glucuronide antibody and magnetic anti-rabbit separation reagent are incubated with diluted sample (250 mL) for 2 hours at 37°C.
A coloured enzyme substrate is incubated with the particles for 1 hour at 37°C. The presence of alkaline phosphatase causes a colour change from yellow to pink. The reaction is terminated by addition of Stop Buffer.
The tubes are then placed in the spectrophotometer or colorimeter. The optical density (at 550nm) of each tube can be measured and the results calculated using a data processing program.